Table 6.

Late toxicity assessment (based on Modified LENT SOMA)

	G1	G2	G3	G4	N0 of patients
At 6 months (subacute)
Hyperpigmentation	22 (34%)	4 (6%)	0	0	65
At 12 months
Fibrosis	28 (43%)	2 (3%)	0	0	65
Hyperpigmentation	3 (5%)	0	0	0	65
At 24 months*
Fibrosis	25 (45%)	2 (3%)	0	0	56
Hyperpigmentation	0	0	0	0	56

* A total of 56 patients seen at 24 months or more with 29 (52%) free of side effects.